Insider Buying: AFLAC Incorporated (NYSE:AFL) Director Acquires 1,000 Shares of Stock

AFLAC Incorporated (NYSE:AFL) Director Karole Lloyd acquired 1,000 shares of the firm’s stock in a transaction that occurred on Thursday, November 7th. The shares were purchased at an average price of $54.08 per share, with a total value of $54,080.00. Following the completion of the acquisition, the director now owns 28,181 shares of the company’s stock, valued at approximately $1,524,028.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Shares of NYSE:AFL traded down $0.18 during mid-day trading on Friday, reaching $53.97. 138,542 shares of the stock were exchanged, compared to its average volume of 2,700,387. The stock’s 50 day simple moving average is $52.57 and its 200-day simple moving average is $52.62. AFLAC Incorporated has a one year low of $41.88 and a one year high of $57.18. The company has a quick ratio of 0.05, a current ratio of 0.05 and a debt-to-equity ratio of 0.21. The company has a market cap of $38.86 billion, a P/E ratio of 12.99, a P/E/G ratio of 3.16 and a beta of 0.71.

AFLAC (NYSE:AFL) last issued its quarterly earnings results on Thursday, October 24th. The financial services provider reported $1.16 EPS for the quarter, beating the consensus estimate of $1.07 by $0.09. AFLAC had a return on equity of 12.45% and a net margin of 13.96%. The firm had revenue of $5.54 billion during the quarter, compared to analysts’ expectations of $5.52 billion. During the same period in the prior year, the firm posted $1.03 earnings per share. The business’s quarterly revenue was down .7% compared to the same quarter last year. Analysts anticipate that AFLAC Incorporated will post 4.43 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Monday, December 2nd. Investors of record on Wednesday, November 20th will be given a dividend of $0.27 per share. The ex-dividend date is Tuesday, November 19th. This represents a $1.08 annualized dividend and a yield of 2.00%. AFLAC’s dividend payout ratio (DPR) is presently 25.96%.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Krane Funds Advisors LLC acquired a new position in AFLAC during the second quarter valued at approximately $25,000. Lenox Wealth Advisors LLC acquired a new position in AFLAC during the third quarter valued at approximately $25,000. Pearl River Capital LLC acquired a new position in AFLAC during the second quarter valued at approximately $27,000. KCS Wealth Advisory acquired a new position in AFLAC during the third quarter valued at approximately $27,000. Finally, Virtus ETF Advisers LLC acquired a new position in AFLAC during the second quarter valued at approximately $32,000. 64.68% of the stock is owned by hedge funds and other institutional investors.

A number of research analysts recently issued reports on AFL shares. Raymond James downgraded AFLAC from a “strong-buy” rating to an “outperform” rating and set a $62.00 price objective for the company. in a report on Monday, July 29th. Morgan Stanley increased their price objective on AFLAC from $53.00 to $54.00 and gave the stock an “equal weight” rating in a report on Friday, July 26th. Bank of America set a $55.00 price objective on AFLAC and gave the stock a “hold” rating in a report on Friday, October 25th. ValuEngine downgraded AFLAC from a “sell” rating to a “strong sell” rating in a report on Thursday, August 1st. Finally, Evercore ISI downgraded AFLAC from an “in-line” rating to an “underperform” rating and set a $56.57 price objective for the company. in a report on Tuesday, July 16th. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and two have given a buy rating to the stock. AFLAC has an average rating of “Hold” and a consensus price target of $53.73.

About AFLAC

Aflac Incorporated, through its subsidiaries, provides voluntary supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans, and annuities in Japan.

See Also: NASDAQ Stock Market Explained

Insider Buying and Selling by Quarter for AFLAC (NYSE:AFL)

Receive News & Ratings for AFLAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AFLAC and related companies with MarketBeat.com's FREE daily email newsletter.